De Weger R A, Pels E, Den Otter W
Immunology. 1982 Nov;47(3):541-50.
Sensitized spleen and peripheral lymph node lymphocytes were tested after different types of immunization with allogeneic tumour cells for their capacity to induce macrophage cytotoxicity in vitro. The macrophages were rendered cytotoxic either by direct contact with lymphocytes and tumour cells (activation of macrophages) or by a factor (macrophage arming factor, MAF), released by the sensitized lymphocytes incubated with tumour cells (arming of macrophages). Both types of reactions are T-cell dependent. Macrophage activation is a more sensitive way to detect lymphocytes with the capacity to render macrophages cytotoxic than arming of macrophages. The route of immunization subcutaneously (s.c.) or intraperitoneally (i.p.) with allogeneic cells did not influence the induction of lymphocytes with the capacity to render macrophages cytotoxic. However, the tumour cells had to be intact as disrupted cells (suspended in Freund's complete adjuvant, FCA) did not induce macrophages activating lymphocytes. The adjuvant dimethyl dioctadecyl ammonium bromide (DDA) did not increase the lymphocyte response. Intact allogeneic tumour cells were needed in vitro when used for secondary antigenic stimulation. This secondary stimulation was independent of antigen presentation by macrophages. This suggests that also in vivo the primary response is independent of macrophage antigen presentation. Delayed-type hypersensitivity and antibody responses against the allogeneic tumour cells were comparable after s.c. and i.p. immunization and after immunization with FCA and DDA.
用同种异体肿瘤细胞进行不同类型免疫后,对致敏的脾脏和外周淋巴结淋巴细胞进行检测,以评估其在体外诱导巨噬细胞细胞毒性的能力。巨噬细胞通过与淋巴细胞和肿瘤细胞直接接触(巨噬细胞活化)或通过与肿瘤细胞一起孵育的致敏淋巴细胞释放的一种因子(巨噬细胞武装因子,MAF)而被赋予细胞毒性(巨噬细胞武装)。这两种反应均依赖于T细胞。与巨噬细胞武装相比,巨噬细胞活化是检测具有使巨噬细胞产生细胞毒性能力的淋巴细胞的更敏感方法。用同种异体细胞进行皮下(s.c.)或腹腔内(i.p.)免疫的途径并不影响具有使巨噬细胞产生细胞毒性能力的淋巴细胞的诱导。然而,肿瘤细胞必须完整,因为破碎的细胞(悬浮在弗氏完全佐剂,FCA中)不会诱导巨噬细胞激活淋巴细胞。佐剂二甲基二十八烷基溴化铵(DDA)不会增加淋巴细胞反应。用于二次抗原刺激时,体外需要完整的同种异体肿瘤细胞。这种二次刺激独立于巨噬细胞的抗原呈递。这表明在体内,初级反应也独立于巨噬细胞抗原呈递。皮下和腹腔内免疫后以及用FCA和DDA免疫后,对同种异体肿瘤细胞的迟发型超敏反应和抗体反应相当。